• Home
  • Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.

Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.

Author List
Watson AN, Shah SA, Shalhoub SD, Piedra KM, Komanduri KV, Kwon D, Pereira DL
Publication
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366110770
Publication Year
2022
PubMed ID
36245321
Publication Title
Watson AN, Shah SA, Shalhoub SD, Piedra KM, Komanduri KV, Kwon D, Pereira DL. Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant. J Oncol Pharm Pract. 2022 Oct 17; 10781552221125871.